Capienda Biotech: Funding, Investors & Team (Oct 2026)
Capienda saves time (1-2 yrs) and cost ($1 Billion) to develop new medicines by opening a key bottleneck in drug discovery. Capienda provides missing results for better small molecule designs: higher quality drugs enter clinical trials. * First high-throughput kinetics system for small molecule drugs. * 48x throughput of Biacore. * Specialist scientists not required. Product is laboratory instrument system + assay chemicals (recurring revenues).
Capienda Biotech has raised $330k across 1 funding round on record, the most recent an undisclosed round of $330k announced in Aug 2025.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Capienda Biotech Company Profile and Key Stats
Latest funding round on record: Aug 2025.
Capienda Biotech Funding Rounds
Capienda Biotech Founders and Leadership Team
No contact details are on record for this team yet.
Capienda Biotech Funding Compared to Other Biotechnology Startups
Capienda Biotech's latest round of $330k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Capienda Biotech in Biotechnology and Carlsbad
Companies Similar to Capienda Biotech
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Capienda Biotech Funding FAQs
What does Capienda Biotech do?
Capienda saves time (1-2 yrs) and cost ($1 Billion) to develop new medicines by opening a key bottleneck in drug discovery. Capienda provides missing results for better small molecule designs: higher quality drugs enter clinical trials. * First high-throughput kinetics system for small molecule drugs. * 48x throughput of Biacore. * Specialist scientists not required. Product is laboratory instrument system + assay chemicals (recurring revenues).
How much funding has Capienda Biotech raised?
Capienda Biotech has raised $330k across 1 round on record. The most recent is an undisclosed round of $330k announced in Aug 2025.
When did Capienda Biotech last raise funding?
Capienda Biotech's most recent funding round on record is an undisclosed round of $330k, announced in Aug 2025.
Who founded Capienda Biotech?
FundedIQ lists Mark Bernard (Founder) at Capienda Biotech.
Where is Capienda Biotech headquartered?
Capienda Biotech is based in Carlsbad, California, United States.
How many employees does Capienda Biotech have?
Capienda Biotech is in the 1-10 employee band.
How does Capienda Biotech's funding compare to other Biotechnology startups?
Capienda Biotech's latest round of $330k is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Capienda Biotech Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Capienda Biotech is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.